Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice
- 8 January 2003
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 17 (1) , 155-159
- https://doi.org/10.1046/j.1460-9568.2003.02409.x
Abstract
Several studies have shown a functional relationship between the endogenous cannabinoid and opioid systems. However, acute effects of Δ9‐tetrahydrocannabinol (THC) and physical dependence were not modified in knockout mice with single deletion of mu (MOR), delta (DOR) or kappa (KOR) opioid receptors. To further investigate the neurobiological basis of cannabinoid dependence, we have evaluated acute pharmacological responses, rewarding effects, tolerance and dependence to THC in double MOR/DOR knockout mice. Antinociception and hypolocomotion induced by acute THC administration remained unaffected, whereas the hypothermic effect was slightly attenuated in these double knockout mice. During chronic THC treatment, knockout mice developed slower tolerance to the hypothermic effect, but the development of tolerance to antinociceptive and hypolocomotor effects was unchanged. The rewarding properties of THC, measured in the conditioned place preference paradigm, were reduced in knockout mice. Interestingly, the somatic manifestations of THC withdrawal were also significantly attenuated in mutant mice, suggesting that a cooperative action of MOR and DOR is required for the entire expression of THC dependence.Keywords
This publication has 26 references indexed in Scilit:
- Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effectEuropean Journal of Neuroscience, 2001
- Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinolBritish Journal of Pharmacology, 1998
- Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic RatsPharmacology Biochemistry and Behavior, 1998
- Antisense Oligodeoxynucleotides to the Kappa1 Receptor Enhance Δ9-THC–Induced Antinociceptive TolerancePharmacology Biochemistry and Behavior, 1998
- Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor MechanismScience, 1997
- Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptorsEuropean Journal of Pharmacology, 1996
- Evidence for a bidirectional cross-tolerance between morphine and Δ9-tetrahydrocannabinol in miceEuropean Journal of Pharmacology, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- δ-Opioid receptor subtypes and cross-talk with μ-receptorsTrends in Pharmacological Sciences, 1993
- A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mousePsychopharmacology, 1978